Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women
NCT00693667
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
92
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoporosis
Interventions
DRUG:
PH3
Sponsor
PhytoHealth Corporation